We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.
Daily historical data with per-account defaults
Filings, earnings, research, and institutional changes — newest first
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
Consensus vs. actual, and revenue trend
| 분기 | 발표일 | 시각 | EPS 예상 | EPS 실제 | 서프라이즈 | 매출 예상 | 매출 실제 | 상태 |
|---|---|---|---|---|---|---|---|---|
| — | 2026. 05. 05. | 장 마감 후 (AMC) | $0.16 | — | — | $173M | — | 예정 |
| FY2026 Q1 | 2025. 03. 31. | 시각 미정 | — | $0.14 | — | — | $167.5M | 보고됨 |
| FY2025 Q3 | 2024. 09. 30. | 시각 미정 | — | $0.11 | — | — | $508.2M |
Rating & price-target changes
| 날짜 | 리서치펌 | 애널리스트 | 액션 | 의견 변화 | 목표가 | 리포트 |
|---|---|---|---|---|---|---|
| 2024. 05. 08. | JMP Securities | — | 의견 유지 | — → Market Perform | — | JMP Securities: Market Perform |
| 2023. 07. 25. | Keybanc | — | 투자의견 하향 | Overweight → Sector Weight | — | Keybanc: Overweight → Sector Weight |
동일 리서치펌의 과거 의견 변화, 동일 섹터 내 다른 종목 액션과 비교 가능
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
미국 증권사 투자의견/등급 변경.
| FY2025 Q2 | 2024. 06. 30. | 시각 미정 | — | $0.02 | — | — | $337.8M | 보고됨 |
공시·실적·기관 변화를 한국어 한 단락으로 요약. 원문 출처와 함께 제공됩니다.
Ranked by position value
표시할 보유 데이터가 없습니다.
신규 편입·전량 매도·비중 변화까지 모두 확인할 수 있습니다.
Avanos Medical, Inc., a medical technology company, provides medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides non-opioid pain solutions, including surgical pain and recovery products, which comprise ON-Q and ambIT surgical pain pump, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which provide minimally invasive pain-relieving therapies, such as COOLIEF chronic pain products; and Trident and Esentec RFA radiofrequency ablation products to treat chronic pain conditions. The company markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. Avanos Medical, Inc. was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. The company was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
Stored first · Google News · Yahoo Finance (English)
Avanos Medical stock hits 52-week high at 25.18 USD By Investing.com - Investing.com Canada
Avanos Medical stock hits 52-week high at 25.18 USD By Investing.com Investing.com Canada
Avanos Medical (NYSE: AVNS) to be acquired for $25.00 per share by AIP‑backed buyer - Stock Titan
Avanos Medical (NYSE: AVNS) to be acquired for $25.00 per share by AIP‑backed buyer Stock Titan
A Look At Avanos Medical (AVNS) Valuation After Its Recent Share Price Surge - simplywall.st
A Look At Avanos Medical (AVNS) Valuation After Its Recent Share Price Surge simplywall.st
New Strong Sell Stocks for May 15th
Deciphering Avanos Medical (AVNS) International Revenue Trends
AVNS Gains After Posting Q1 Earnings Miss & Revenue Beat, Margins Down